Breaking Down Barriers: Innovative Approaches for Streamlining Access to Rare Disease Therapies
ACRPNet • Tue Apr 08 2025
Hope is often the driving force behind the relentless work of research teams dedicated to developing transformative therapies for the millions of individuals and families impacted by rare diseases. Through collaboration with manufacturers, patients, advocates, and clinicians, these researchers are advancing promising therapies into clinical trials and pioneering innovative tools and technologies that offer hope to the 300 million people worldwide living with a rare disease—95% of whom still lack effective treatment options.
Hope is often the driving force behind the relentless work of research teams dedicated to developing transformative therapies for the millions of individuals and families impacted by rare diseases. Through collaboration with manufacturers, patients, advocates, and clinicians, these researchers are advancing promising therapies into clinical trials and pioneering innovative tools and technologies that offer hope to the 300 million people worldwide living with a rare disease—95% of whom still lack effective treatment options.
To read more, click here
About AscellaHealth
Healthcare today is more complex than ever—especially when it comes to therapies for people living with rare and chronic conditions. These high-cost, high-impact treatments account for only a small fraction of prescriptions, but they make up the largest and fastest-growing share of total drug spend. As a result, balancing affordability and quality of care remains a significant challenge.
We’re here to change that.
Because at AscellaHealth, we believe that all patients in need should have the ability to access life-changing therapies.
Our Core Beliefs
At AscellaHealth, patients are not just part of the process—they’re why we do what we do. Every solution we build and every partnership we form is designed with the patient in mind.
Patients First, Always.
Balancing Cost and Care.
Better Stakeholder Outcomes.